About: Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2000 (uk) im August 2000 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en août 2000 (fr) artículu científicu espublizáu n'agostu de 2000 (ast) scientific article published on 01 August 2000 (en)
publication date	wds:Q56944772-FB88FA46-ACAE-4993-A7E2-0888B221A84E
publication date	2000-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56944772-88CB8035-05B4-49A4-B2BB-100AB3FE771E
language of work or name	English
cites work	wds:Q56944772-052A3F6C-CA5F-483B-ACDD-4B2946A034B0 wds:Q56944772-1DC41886-286E-41F6-88CE-BA81A7DE7198 wds:Q56944772-2763050A-D720-4EBA-833E-6D43210C5C22 wds:Q56944772-27660285-A92E-496B-B97F-97FDBE318B16 wds:Q56944772-3449AC5F-8140-4816-B4B0-B97C516E1435 wds:Q56944772-35FD9BAB-5844-4383-AD70-3073B335CE43 wds:Q56944772-5A2A4FDF-D513-4ACF-B795-4ABD782209EB wds:Q56944772-64154972-0937-458E-80DB-9AA07A1D3178 wds:Q56944772-6D2E9B11-C245-4523-B55C-7208EA2F2064 wds:Q56944772-7B8C8EA9-B515-4529-A220-32A6A82697EB wds:Q56944772-86729097-D903-4647-B245-601FFD0CEB70 wds:Q56944772-8A60B74E-6921-4A4E-99A2-19CB06F81879 wds:Q56944772-936E8219-04FD-4C5B-83A4-B354CF4A8890 wds:Q56944772-964B3DA7-842C-4245-84A2-9F17C54428DE wds:Q56944772-9CEC8B55-8131-41BD-8829-3A1445746718 wds:Q56944772-9DCE4206-E664-42A6-94F8-883EF22747B2 wds:Q56944772-9FBDE285-1E98-491F-96B3-4F7E1F0A05B6 wds:Q56944772-A34D3A7B-67A2-44B1-95BC-7F4E9F5BFD9F wds:Q56944772-BBF61209-9FE5-40B0-ABD9-FA98226119F0 wds:Q56944772-C2769567-7068-444C-8BBB-726B86670F60 wds:Q56944772-C46DCF0B-DC83-452C-8313-9844602C6588 wds:Q56944772-C5254BAF-6E45-4F8B-A55B-6F376F605A45 wds:Q56944772-E80AAA82-5A6C-4A72-A04A-585AF9572B9B wds:Q56944772-F6331162-1BF1-4303-9B34-EDB5D9DD725E
cites work	Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study. Practice strategies for elective red blood cell transfusion. American College of Physicians Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: increased costs and platelet transfusion requirements after the use of abciximab Abciximab and excessive bleeding in patients undergoing emergency cardiac operations Surgical implications of platelet glycoprotein IIb-IIIa inhibition Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Intracardiac thrombus: a risk of incomplete anticoagulation for cardiac operations Integrilin prevents prolonged bleeding times after cardiopulmonary bypass. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years Disrupted coronary artery caused by angioplasty: supportive and surgical considerations Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management
author name string	wds:Q56944772-0D63C2B3-CF7B-449B-A215-11C5EFBF6F43 wds:Q56944772-17E5B99A-A811-4262-B836-C7076D9C6B0E wds:Q56944772-2C43615F-22F2-41E0-9509-668376BEFC51 wds:Q56944772-314B7733-C5CF-4573-B25A-08F9D712C625 wds:Q56944772-3C9EBF0B-1A1C-4E20-9996-C26616B8D436 wds:Q56944772-584764C1-5ADB-4621-8C45-7C300C1D128C wds:Q56944772-A5109F8A-3617-4698-93B4-79932DE8D7AA wds:Q56944772-B180AAA6-C119-442C-B875-11EE6517657A wds:Q56944772-C7C281F1-9621-4F8A-9ED9-904A7DAEEE09
author name string	J E Tcheng M B Effron C F Cabot J E Booth S K Sapp P K Smith G J Despotis R E Raymond L A LeNarz
rdfs:label	Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (nl) Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP (en)
skos:prefLabel	Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (nl) Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP (en)
name	Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (nl) Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP (en)
author	wds:Q56944772-120B8967-2DA7-40AC-B11B-0AC188A1A025 wds:Q56944772-2631C428-C0ED-47B0-9900-21DDB17B31A0 wds:Q56944772-97EDF844-2712-4F79-BC12-AA12949D15A2 wds:Q56944772-AC5A6AD4-7A50-498B-B5E4-4CFB08CC2F55
author	Robert Califf Eric J. Topol A Michael Lincoff John Ducas
title	wds:Q56944772-96E04B96-6064-4896-B5CD-C97807D5ED0C
title	Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing (en)
page(s)	wds:Q56944772-51933D73-CB4B-48EA-A584-B4A70D377EFB
page(s)	516-526
instance of	wds:Q56944772-2F689AC0-343B-470F-8983-ABE237C7A94B
instance of	scholarly article
PubMed ID	wds:Q56944772-2F8A3701-4F03-4ABA-BAFF-CD6E44E12159
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10969673
PubMed ID	10969673

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software